These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 15474693
1. Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Gackowski A, Isnard R, Golmard JL, Pousset F, Carayon A, Montalescot G, Hulot JS, Thomas D, Piwowarska W, Komajda M. Eur Heart J; 2004 Oct; 25(20):1788-96. PubMed ID: 15474693 [Abstract] [Full Text] [Related]
4. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification. Faggiano P, Valle R, Aspromonte N, D'Aloia A, Di Tano G, Barro S, Giovinazzo P, Milani L, Lorusso R, Dei Cas L. Int J Cardiol; 2010 Apr 01; 140(1):88-94. PubMed ID: 19321212 [Abstract] [Full Text] [Related]
6. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern. Feola M, Aspromonte N, Milani L, Bobbio M, Bardellotto S, Barro S, Giovinazzo P, Noventa F, Valle R. J Card Fail; 2008 Jun 01; 14(5):420-5. PubMed ID: 18514935 [Abstract] [Full Text] [Related]
7. Prognostic role of B-type natriuretic peptide in patients with diabetes and acute decompensated heart failure. Aspromonte N, Feola M, Milli M, Scardovi AB, Coletta C, Carbonieri E, Giovinazzo P, Di Giacomo T, Barro S, Rosso GL, Ceci V, Milani L, Valle R. Diabet Med; 2007 Feb 01; 24(2):124-30. PubMed ID: 17257273 [Abstract] [Full Text] [Related]
8. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. Cohen-Solal A, Logeart D, Huang B, Cai D, Nieminen MS, Mebazaa A. J Am Coll Cardiol; 2009 Jun 23; 53(25):2343-8. PubMed ID: 19539144 [Abstract] [Full Text] [Related]
12. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea]. Arquès S, Roux E, Sbragia P, Pieri B, Gélisse R, Luccioni R, Ambrosi P. Arch Mal Coeur Vaiss; 2007 Feb 23; 100(2):113-20. PubMed ID: 17474496 [Abstract] [Full Text] [Related]
13. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease. Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R. Am J Cardiol; 2008 Aug 15; 102(4):469-74. PubMed ID: 18678308 [Abstract] [Full Text] [Related]
19. Clinical status and B-type natriuretic peptide levels in patients with heart failure at hospital discharge. Oral I, Mistrík J, Náplava R. Herz; 2007 Oct 15; 32(7):583-8. PubMed ID: 17972033 [Abstract] [Full Text] [Related]
20. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Maisel AS. Am Heart J; 2006 May 15; 151(5):999-1005. PubMed ID: 16644321 [Abstract] [Full Text] [Related] Page: [Next] [New Search]